[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Assertio Therapeutics Inc (ASRT)

Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 151,474
  • Shares Outstanding, K 6,462
  • Annual Sales, $ 118,710 K
  • Annual Income, $ -30,380 K
  • EBIT $ 1 M
  • EBITDA $ 32 M
  • 60-Month Beta 0.44
  • Price/Sales 1.27
  • Price/Cash Flow 1,429.34
  • Price/Book 1.99

Options Overview Details

View History
  • Implied Volatility 96.44% (+19.59%)
  • Historical Volatility 45.57%
  • IV Percentile 11%
  • IV Rank 12.36%
  • IV High 748.29% on 12/23/25
  • IV Low 4.53% on 04/16/26
  • Expected Move (DTE 25) 0.04 (0.18%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 5,257
  • Open Int (30-Day) 5,286
  • Expected Range 23.40 to 23.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.07
  • Number of Estimates 1
  • High Estimate $-0.07
  • Low Estimate $-0.07
  • Prior Year $-2.55
  • Growth Rate Est. (year over year) +97.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.02 +30.08%
on 04/24/26
23.46 -0.09%
on 05/19/26
+5.41 (+30.01%)
since 04/22/26
3-Month
11.05 +112.13%
on 03/03/26
23.46 -0.09%
on 05/19/26
+11.60 (+97.97%)
since 02/20/26
52-Week
8.61 +172.24%
on 12/31/25
23.46 -0.09%
on 05/19/26
+12.79 (+120.00%)
since 05/22/25

Most Recent Stories

More News
$HAREHOLDER ALERT: The M&A Class Action Continues to Investigate the Merger--ASRT, SILA, KW, and UNF

NEW YORK , May 22, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...

ASRT : 23.44 (+0.30%)
KW : 10.99 (-0.09%)
UNF : 265.47 (+0.26%)
SILA : 30.21 (-0.13%)
Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

CNTA : 39.75 (-0.15%)
ASRT : 23.44 (+0.30%)
SEM : 16.52 (-0.12%)
UNF : 265.47 (+0.26%)
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Assertio Holdings ...

ASRT : 23.44 (+0.30%)
Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE , May 13, 2026 /PRNewswire/ -- Ademi LLP is investigating Assertio (NASDAQ: ASRT) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction...

ASRT : 23.44 (+0.30%)
Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash

All-Cash Tender Offer of $23.50 per share or $166.4 Million Offer Represents 30.6% Premium to Original Agreement with Garda Therapeutics AND 75.8% Premium to Unaffected...

ASRT : 23.44 (+0.30%)
Assertio and Garda Mutually Agree to Delay Launch of Tender Offer

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to delay the launch of the...

ASRT : 23.44 (+0.30%)
Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to postpone the commencement...

ASRT : 23.44 (+0.30%)
Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics

Increased All-Cash Tender Offer Price of $21.80 per share – or $153.2 Million New Tender Offer Price Represents 21.1% Premium to Prior Offer

ASRT : 23.44 (+0.30%)
Assertio and Garda Mutually Agree to Extend Tender Offer Deadline

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to extend the deadline to...

ASRT : 23.44 (+0.30%)
Assertio Provides Update on Garda Therapeutics Tender Process

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today provided an update that Garda Therapeutics, Inc. (“Garda”) intends to commence the tender offer to acquire all outstanding...

ASRT : 23.44 (+0.30%)

Business Summary

Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc.,...

See More

Key Turning Points

3rd Resistance Point 23.54
2nd Resistance Point 23.49
1st Resistance Point 23.47
Last Price 23.44
1st Support Level 23.40
2nd Support Level 23.35
3rd Support Level 23.33

See More

52-Week High 23.46
Last Price 23.44
Fibonacci 61.8% 17.79
Fibonacci 50% 16.03
Fibonacci 38.2% 14.28
52-Week Low 8.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.